RxDoctor Payments Data

Robert Hoover, MD

Nephrology · New Orleans, LANPI 1255492088

Payments from drug & device makers

What this record shows

9 manufacturers reported payments, led by Janssen Global Services, LLC at 52.4% of the total. Reporting peaked in 2022 at $890 and has fallen 90.6% since, to $84 in 2025. That places this record below the midpoint for nephrology clinicians in LA, where the typical reported total is $1,900.

$1,394in general payments, 2019–2025

Across 18 payments — averaging $77.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Global Services, LLC$730
  • Calliditas Therapeutics US Inc.$153
  • Genentech, Inc.$113
  • Vertex$111
  • Akebia Therapeutics Inc$104
  • Mallinckrodt Hospital Products Inc.$100
  • plus $82 from 3 others
$181,950in research payments, 2019–2025

Across 5 payments — averaging $36,390 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$182K

What the payments were for

  • Travel & lodging$73052%
  • Food & beverage$66448%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,394 in reported general payments places this provider in the 40th percentile of 206 nephrology providers in Louisiana.

See all nephrology providers in Louisiana

Medicare billing

Part B allowed, 2024
$5,972
Medicare patients
23
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →